LAS VEGAS, NV / ACCESSWIRE / June 9, 2020 / Alkame Holdings, Inc. (OTC PINK:ALKM), a publicly-traded holding company announced today that its wholly-owned specialty food and beverage manufacturing subsidiary, West Coast Co Packer, Inc. has signed a lease for its new production facility in Salem, Oregon.
West Coast Co Packer, Inc. specializes in specialty liquid single-serve sachets, bottling and co-packing for existing brands, and a private label contract manufacturing. West Coast Co Pack, Inc., is a Bell Foods satellite production facility in Salem, Oregon, located in close proximity to Alkame's original manufacturing campus.
The new location is expected to be fully operational during the month of June 2020.
West Coast Co Packer, Inc. is a specialty liquid and single-serve manufacturer, co-packer, private labeler, and contract packager and is expected to immediately complement and seamlessly integrate with Alkame's other subsidiaries including Bell Food and Beverage, Inc. Bell Food and Beverage, Inc. is a specialty natural, organic liquid-based hot and cold fill food & beverage manufacturer in glass and PET bottles and jars.
About Alkame Holdings, Inc.
Alkame Holdings, Inc. is a publicly-traded health and wellness technology holding company, with a focus on patentable, innovative, and eco-friendly consumer products. The Company's wholly-owned subsidiaries manufacture products with enhanced water utilizing proprietary technology to create products with several unique properties. The organization is diligently building a strong foundation through the launch and acquisition of appropriate business assets, and by pursuing multiple applications and placement into several emerging business sectors, such as consumer bottled water and RTD products, liquid hemp products, household pet products, horticulture, agriculture, and medical applications, including hand sanitizers, and many other various water-based treatment solutions to both new and existing business platforms.
For more information, visit www.alkameholdingsinc.
Disclaimer/Safe Harbor: This news release contains forward-looking statements within the meaning of the Securities Litigation Reform Act. The statements reflect the Company's current views with respect to future events that involve risks and uncertainties. Among others, these risks include the expectation that Alkame will achieve significant sales, the failure to meet schedule or performance requirements of the Company's contracts, the Company's liquidity position, the Company's ability to obtain new contracts, the emergence of competitors with greater financial resources and the impact of competitive pricing. In the light of these uncertainties, the forward-looking events referred to in this release might not occur. These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure or prevent any disease.
SOURCE: Alkame Holdings, Inc.